Stem cell repopulation efficiency but not pool size is governed by p27kip1
Top Cited Papers
- 1 November 2000
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 6 (11) , 1235-1240
- https://doi.org/10.1038/81335
Abstract
Sustained blood cell production requires preservation of a quiescent, multipotential stem cell pool that intermittently gives rise to progenitors with robust proliferative potential. The ability of cells to shift from a highly constrained to a vigorously active proliferative state is critical for maintaining stem cells while providing the responsiveness necessary for host defense. The cyclin-dependent kinase inhibitor (CDKI), p21cip1/waf1 (p21) dominates stem cell kinetics. Here we report that another CDKI, p27kip1 (p27), does not affect stem cell number, cell cycling, or self-renewal, but markedly alters progenitor proliferation and pool size. Therefore, distinct CDKIs govern the highly divergent stem and progenitor cell populations. When competitively transplanted, p27-deficient stem cells generate progenitors that eventually dominate blood cell production. Modulating p27 expression in a small number of stem cells may translate into effects on the majority of mature cells, thereby providing a strategy for potentiating the impact of transduced cells in stem cell gene therapy.Keywords
This publication has 35 references indexed in Scilit:
- Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitorsExperimental Hematology, 1999
- Cancer Cell CyclesScience, 1996
- Transcriptional Activation of the Human p21 Gene by Retinoic Acid ReceptorJournal of Biological Chemistry, 1996
- Abrogation of p27 by cDNA Antisense Suppresses Quiescence (G0 State) in FibroblastsJournal of Biological Chemistry, 1996
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin.The Journal of Experimental Medicine, 1994
- p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.Genes & Development, 1994
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992
- Purification and Characterization of Mouse Hematopoietic Stem CellsScience, 1988